UY27824A1 - NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE. - Google Patents

NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE.

Info

Publication number
UY27824A1
UY27824A1 UY27824A UY27824A UY27824A1 UY 27824 A1 UY27824 A1 UY 27824A1 UY 27824 A UY27824 A UY 27824A UY 27824 A UY27824 A UY 27824A UY 27824 A1 UY27824 A1 UY 27824A1
Authority
UY
Uruguay
Prior art keywords
parenteral administration
crobenetine
new formulation
new
formulation
Prior art date
Application number
UY27824A
Other languages
Spanish (es)
Inventor
Dr Bernd Kruss
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27824A1 publication Critical patent/UY27824A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a una nueva formulación que contiene crobenetina o una de sus sales farmacéuticamente aceptables, para administración por vía parenteral.The invention relates to a new formulation containing crobenetin or a pharmaceutically acceptable salt thereof, for parenteral administration.

UY27824A 2002-05-29 2003-05-27 NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE. UY27824A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10223784A DE10223784A1 (en) 2002-05-29 2002-05-29 New formulation for parenteral administration of crobenetine

Publications (1)

Publication Number Publication Date
UY27824A1 true UY27824A1 (en) 2003-12-31

Family

ID=29432394

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27824A UY27824A1 (en) 2002-05-29 2003-05-27 NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE.

Country Status (10)

Country Link
EP (1) EP1511487A1 (en)
JP (1) JP2005531573A (en)
AR (1) AR040135A1 (en)
AU (1) AU2003240699A1 (en)
CA (1) CA2487153A1 (en)
DE (1) DE10223784A1 (en)
PE (1) PE20040067A1 (en)
TW (1) TW200406205A (en)
UY (1) UY27824A1 (en)
WO (1) WO2003099280A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10223783A1 (en) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma New formulation for parenteral administration of a Na-channel blocker

Also Published As

Publication number Publication date
DE10223784A1 (en) 2003-12-11
PE20040067A1 (en) 2004-03-30
CA2487153A1 (en) 2003-12-04
AR040135A1 (en) 2005-03-16
EP1511487A1 (en) 2005-03-09
AU2003240699A1 (en) 2003-12-12
WO2003099280A1 (en) 2003-12-04
TW200406205A (en) 2004-05-01
JP2005531573A (en) 2005-10-20

Similar Documents

Publication Publication Date Title
HN2003000408A (en) NEW DERIVATIVES OF HETEROCICLIC FLUOROGLYCOSIDES, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME.
CY1113003T1 (en) LAQUINIMOD STABLE PREPARATIONS
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
HN2003000407A (en) NEW DERIVATIVES OF AROMATIC FLUOROGLYCOSISES, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USES.
UY28348A1 (en) NEW COMPOUNDS
ECSP055786A (en) SPIROCYCLIC CYCLHEXAN DERIVATIVES
HN2006019066A (en) "(S) -N-METHYLNTREXONE"
ECSP045491A (en) NEW VENLAFAXINA O-DESMETIL FORMAMATE SALT
HN2003000183A (en) DIFENILAZETIDINONAS REPLACED IN RING PROCEDURE FOR PREPARATION, MEDICATIONS THAT UNDERSTAND THESE COMPOUNDS AND THEIR USE.
ECSP045221A (en) SALTS OF VALSARTAN
ECSP066291A (en) EMULSIONING SYSTEMS CONTAINING DERIVATIVES OF AZETIDINE
HN2004000109A (en) NEW DIFENYLAZETHYDINONE WITH IMPROVED PHYSIOLOGICAL PROPERTIES, PROCEDURE FOR THEIR PREPARATION, DRUGS THAT UNDERSTAND THIS COMPOSITE AND ITS USE
NO20064808L (en) Oral matrix formulations with licarbazepine
CO5700723A2 (en) USE OF A SPECIFIC CYCLIC AMINE DERIVATIVE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT AND PREVENT CARDIAC INSUFFICIENCY
CR7648A (en) MICROCAPSULES FOR DELAYED AND CONTROLLED LIBERATION OF PERINDROPIL
ECSP066292A (en) SEMI-SOLID SYSTEMS CONTAINING DERIVATIVES OF AZETIDINE
UY27824A1 (en) NEW FORMULATION FOR THE PARENTERAL ADMINISTRATION OF CROBENETINE.
UY27620A1 (en) AMBROXOLL FOR THE TREATMENT OF CHRONIC PAIN
ITRM20030074A0 (en) SEMISOLID IMMEDIATE RELEASE FORMULATIONS INTENDED FOR THE ORAL ADMINISTRATION OF DRUGS.
ECSP034708A (en) NEW BENZOILGUANIDINA SALT
UY27823A1 (en) NEW FORMULATION FOR PARENTERAL ADMINISTRATION OF A BLOCKER OF THE CANAL DEL NA
GT199800008A (en) PROCEDURE FOR THE PREPARATION OF A TETRAHYDROPYRIDINE DERIVATIVE.
DK1399143T3 (en) The use of Acetyl L-carnitine in the manufacture of a medicament for the treatment of anhedonia
CL2003002077A1 (en) USE OF A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INHIBITOR OF THE RECOVERY OF SELECTED NOREPINEFRINE BETWEEN MAPROTILINE, NORPRAMINE, DESIPRAMINE, NISOXETINE, ATOMOXETINE, AMOXAPINE, DEXEPIN, LOFEPRAMINE, AMTRIPTILIN
HN1999000128A (en) NEW PHARMACEUTICAL USES FOR INHIBITORS US.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150223